CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.
Alajati, Abdullah
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. [electronic resource] - The Journal of clinical investigation 05 2020 - 2435-2450 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1558-8238
10.1172/JCI131133 doi
Animals
Antigens, Neoplasm--biosynthesis
Benzamides
Cell Adhesion Molecules--biosynthesis
Cell Line, Tumor
Drosophila melanogaster
Gene Expression Regulation, Neoplastic
Humans
Liposomes
MAP Kinase Signaling System
Male
Nitriles
PTEN Phosphohydrolase--biosynthesis
Phenylthiohydantoin--analogs & derivatives
Prostatic Neoplasms--drug therapy
Up-Regulation
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. [electronic resource] - The Journal of clinical investigation 05 2020 - 2435-2450 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1558-8238
10.1172/JCI131133 doi
Animals
Antigens, Neoplasm--biosynthesis
Benzamides
Cell Adhesion Molecules--biosynthesis
Cell Line, Tumor
Drosophila melanogaster
Gene Expression Regulation, Neoplastic
Humans
Liposomes
MAP Kinase Signaling System
Male
Nitriles
PTEN Phosphohydrolase--biosynthesis
Phenylthiohydantoin--analogs & derivatives
Prostatic Neoplasms--drug therapy
Up-Regulation